Sapporo Medical University is a public university in Chūō-ku, Sapporo, Hokkaidō, Japan. The precursor of the school was founded in 1945, and it was chartered as a university in 1950.

During the past decade, Sapporo Medical University conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sapporo Medical University" #1 sponsor was "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 3 trials, followed by "Fresenius Kabi Japan" with 2 trials sponsored, "Japan Rhabdomyosarcoma Study Group" with 2 trials sponsored, "Alexion" with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sapporo Medical University" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator, "Japan Clinical Research Support Unit(J-CRSU)" with 1 trials as a collaborator, "Kurosawa Hospital" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "United BioSource, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Sapporo Medical University" are "Colorectal Cancer" (2 trials), "Sarcoma" (2 trials), "Advanced Hepatocellular Carcinoma" (1 trials), "Brain Injuries, Traumatic" (1 trials) and "Carcinoma" (1 trials). Many other conditions were trialed in "Sapporo Medical University" in a lesser frequency.

Most popular intervention types in "Sapporo Medical University" are "Drug" (10 trials), "Biological" (3 trials), "Other" (2 trials), "Radiation" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "UFT adjuvant chemotherapy" (2 trials), "cyclophosphamide" (2 trials), "dactinomycin" (2 trials), "vincristine sulfate" (2 trials) and "1: Hydroxyethyl starch 130/0.4, 6 %" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sapporo Medical University" are 13 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Sapporo Medical University". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Sapporo Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sapporo Medical University, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".